Birdwatch Note
2024-10-16 17:11:33 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Ivermectin has and continues to be studied as a potential cancer treatment alongside proven effective treatments, but has not been tested in human trials, or approved for use by Health Canada, the U.S. FDA, or EMA. Use of this drug without medical oversight can be dangerous. https://pmc.ncbi.nlm.nih.gov/articles/PMC7205794/ https://www.drugs.com/sfx/ivermectin-side-effects.html
Written by 77B46CC47B764A1ECB965652084D53231C922241057B9E03C059970671D4A2E1
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1846497859882864960
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1846599877775536381
- noteId - 1846599877775536381
- participantId -
- noteAuthorParticipantId - 77B46CC47B764A1ECB965652084D53231C922241057B9E03C059970671D4A2E1 Participant Details
- createdAtMillis - 1729098693685
- tweetId - 1846497859882864960
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Ivermectin has and continues to be studied as a potential cancer treatment alongside proven effective treatments, but has not been tested in human trials, or approved for use by Health Canada, the U.S. FDA, or EMA. Use of this drug without medical oversight can be dangerous. https://pmc.ncbi.nlm.nih.gov/articles/PMC7205794/ https://www.drugs.com/sfx/ivermectin-side-effects.html
Note Ratings
| rated at | rated by | |
| 2024-10-17 15:49:42 -0500 | Rating Details | |
| 2024-10-17 12:54:58 -0500 | Rating Details | |
| 2024-10-17 11:42:38 -0500 | Rating Details | |
| 2024-10-17 08:17:46 -0500 | Rating Details | |
| 2024-10-17 08:10:19 -0500 | Rating Details | |
| 2024-10-16 23:09:15 -0500 | Rating Details | |
| 2024-10-16 23:01:48 -0500 | Rating Details | |
| 2024-10-16 21:05:52 -0500 | Rating Details | |
| 2024-10-16 21:02:13 -0500 | Rating Details | |
| 2024-10-16 20:53:44 -0500 | Rating Details | |
| 2024-10-16 20:05:49 -0500 | Rating Details | |
| 2024-10-16 18:23:13 -0500 | Rating Details | |
| 2024-10-16 17:53:03 -0500 | Rating Details | |
| 2024-10-16 17:52:20 -0500 | Rating Details | |
| 2024-10-16 16:35:54 -0500 | Rating Details | |
| 2024-10-16 15:57:02 -0500 | Rating Details | |
| 2024-10-16 14:14:31 -0500 | Rating Details | |
| 2024-10-16 13:41:34 -0500 | Rating Details | |
| 2024-10-20 08:06:02 -0500 | Rating Details | |
| 2024-10-18 15:29:00 -0500 | Rating Details | |
| 2024-10-17 10:47:10 -0500 | Rating Details | |
| 2024-10-17 07:41:10 -0500 | Rating Details | |
| 2024-10-17 02:02:42 -0500 | Rating Details | |
| 2024-10-16 23:07:54 -0500 | Rating Details | |
| 2024-10-16 21:38:50 -0500 | Rating Details | |
| 2024-10-16 17:16:28 -0500 | Rating Details | |
| 2024-10-16 17:05:52 -0500 | Rating Details | |
| 2024-10-16 16:20:34 -0500 | Rating Details | |
| 2024-10-16 16:19:00 -0500 | Rating Details | |
| 2024-10-16 15:41:52 -0500 | Rating Details | |
| 2024-10-16 14:59:01 -0500 | Rating Details | |
| 2024-10-16 14:18:45 -0500 | Rating Details | |
| 2024-10-16 13:28:12 -0500 | Rating Details | |
| 2024-10-16 12:19:25 -0500 | Rating Details | |
| 2024-11-01 14:09:45 -0500 | Rating Details | |
| 2024-10-19 16:19:01 -0500 | Rating Details | |
| 2024-10-17 16:12:32 -0500 | Rating Details | |
| 2024-10-17 10:51:43 -0500 | Rating Details | |
| 2024-10-17 08:25:03 -0500 | Rating Details | |
| 2024-10-17 05:39:46 -0500 | Rating Details | |
| 2024-10-17 05:15:02 -0500 | Rating Details | |
| 2024-10-16 22:25:36 -0500 | Rating Details | |
| 2024-10-16 20:20:03 -0500 | Rating Details | |
| 2024-10-16 15:32:37 -0500 | Rating Details | |
| 2024-10-16 15:09:25 -0500 | Rating Details | |
| 2024-10-20 12:45:19 -0500 | Rating Details | |
| 2024-10-17 02:33:19 -0500 | Rating Details | |
| 2024-10-17 02:05:52 -0500 | Rating Details | |
| 2024-10-16 23:28:45 -0500 | Rating Details | |
| 2024-10-16 16:00:40 -0500 | Rating Details | |
| 2024-10-16 15:01:06 -0500 | Rating Details | |
| 2024-10-16 13:53:07 -0500 | Rating Details | |
| 2024-10-16 13:05:31 -0500 | Rating Details | |
| 2024-10-17 17:52:42 -0500 | Rating Details | |
| 2024-10-17 04:11:58 -0500 | Rating Details | |
| 2024-10-17 03:53:33 -0500 | Rating Details | |
| 2024-10-17 01:30:07 -0500 | Rating Details | |
| 2024-10-16 23:25:23 -0500 | Rating Details | |
| 2024-10-16 20:36:43 -0500 | Rating Details | |
| 2024-10-16 15:29:04 -0500 | Rating Details | |
| 2024-10-16 14:22:12 -0500 | Rating Details | |
| 2024-10-16 14:13:16 -0500 | Rating Details | |
| 2024-10-16 13:35:42 -0500 | Rating Details | |
| 2024-10-16 13:11:59 -0500 | Rating Details |